These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34707863)

  • 1. TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4
    Holder KA; Burt K; Grant MD
    Clin Transl Immunology; 2021; 10(10):e1348. PubMed ID: 34707863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir.
    Holder KA; Grant MD
    Front Cell Infect Microbiol; 2020; 10():175. PubMed ID: 32432050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
    AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
    Zhou X; Du J; Wang H; Chen C; Jiao L; Cheng X; Zhou X; Chen S; Gou S; Zhao W; Zhai W; Chen J; Gao Y
    Cell Commun Signal; 2020 Sep; 18(1):142. PubMed ID: 32894141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth
    Zhou XM; Li WQ; Wu YH; Han L; Cao XG; Yang XM; Wang HF; Zhao WS; Zhai WJ; Qi YM; Gao YF
    Front Immunol; 2018; 9():2821. PubMed ID: 30555485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIGIT Expression on Activated NK Cells Correlates with Greater Anti-Tumor Activity but Promotes Functional Decline upon Lung Cancer Exposure: Implications for Adoptive Cell Therapy and TIGIT-Targeted Therapies.
    Hasan MF; Croom-Perez TJ; Oyer JL; Dieffenthaller TA; Robles-Carrillo LD; Eloriaga JE; Kumar S; Andersen BW; Copik AJ
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8 + T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine.
    Jin J; Wang X; Li Y; Yang X; Wang H; Han X; Sun J; Ma Z; Duan J; Zhang G; Huang T; Zhang T; Wu H; Zhang X; Su B
    Chin Med J (Engl); 2023 Dec; 136(24):2938-2947. PubMed ID: 37963586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models.
    Chen X; Xue L; Ding X; Zhang J; Jiang L; Liu S; Hou H; Jiang B; Cheng L; Zhu Q; Zhang L; Zhou X; Ma J; Liu Q; Li Y; Ren Z; Jiang B; Song X; Song J; Jin W; Wei M; Shen Z; Liu X; Wang L; Li K; Zhang T
    Front Immunol; 2022; 13():828319. PubMed ID: 35273608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
    Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
    J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
    Shibuya A; Shibuya K
    Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies.
    Hasan MF; Campbell AR; Croom-Perez TJ; Oyer JL; Dieffenthaller TA; Robles-Carrillo LD; Cash CA; Eloriaga JE; Kumar S; Andersen BW; Naeimi Kararoudi M; Tullius BP; Lee DA; Copik AJ
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38081778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
    Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
    Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Exhaustion of T Cells in Alveolar Echinococcosis Patients and Its Reversal by Blocking Checkpoint Receptor TIGIT in a Murine Model.
    Zhang C; Lin R; Li Z; Yang S; Bi X; Wang H; Aini A; Zhang N; Abulizi A; Sun C; Li L; Zhao Z; Qin R; Li X; Li L; Aji T; Shao Y; Vuitton DA; Tian Z; Wen H
    Hepatology; 2020 Apr; 71(4):1297-1315. PubMed ID: 31410870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TIGIT for cancer immunotherapy: recent advances and future directions.
    Zhang P; Liu X; Gu Z; Jiang Z; Zhao S; Song Y; Yu J
    Biomark Res; 2024 Jan; 12(1):7. PubMed ID: 38229100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbed CD8
    Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
    Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Characteristics of TIGIT-Expressing CD3
    Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
    Front Immunol; 2021; 12():602492. PubMed ID: 33717085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.
    Blanch-Lombarte O; Ouchi D; Jimenez-Moyano E; Carabelli J; Marin MA; Peña R; Pelletier A; Talla A; Sharma A; Dalmau J; Santos JR; Sékaly RP; Clotet B; Prado JG
    Elife; 2023 Sep; 12():. PubMed ID: 37723971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.
    Siebert N; Zumpe M; Schwencke CH; Biskupski S; Troschke-Meurer S; Leopold J; Zikoridse A; Lode HN
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
    Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
    Cancer Res; 2016 Oct; 76(19):5696-5706. PubMed ID: 27503932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.